Core Laboratories (NYSE:CLB) Stock Passes Above 200-Day Moving Average – Here’s What Happened

Core Laboratories Inc. (NYSE:CLB) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $14.71 and traded as high as $18.76. Core Laboratories shares last traded at $18.5580, with a volume of 363,903 shares trading hands.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “hold (c)” rating on shares of Core Laboratories in a report on Monday, December 29th. Four analysts have rated the stock with a Hold rating, According to data from MarketBeat, Core Laboratories presently has an average rating of “Hold” and an average target price of $12.50.

Core Laboratories Price Performance

The firm’s fifty day simple moving average is $18.01 and its 200-day simple moving average is $14.71. The firm has a market capitalization of $864.12 million, a PE ratio of 27.70, a PEG ratio of 15.84 and a beta of 1.09. The company has a quick ratio of 1.57, a current ratio of 2.07 and a debt-to-equity ratio of 0.39.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings results on Wednesday, February 4th. The oil and gas company reported $0.21 EPS for the quarter, beating analysts’ consensus estimates of $0.20 by $0.01. The firm had revenue of $138.26 million for the quarter, compared to analysts’ expectations of $130.40 million. Core Laboratories had a net margin of 6.04% and a return on equity of 12.09%. The business’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.22 earnings per share. Core Laboratories has set its Q1 2026 guidance at 0.110-0.150 EPS. On average, research analysts forecast that Core Laboratories Inc. will post 0.96 earnings per share for the current fiscal year.

Core Laboratories Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 9th. Shareholders of record on Monday, February 16th will be issued a $0.01 dividend. The ex-dividend date of this dividend is Friday, February 13th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.2%. Core Laboratories’s dividend payout ratio (DPR) is presently 5.97%.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in Core Laboratories by 4.4% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 27,893 shares of the oil and gas company’s stock worth $418,000 after buying an additional 1,170 shares in the last quarter. Vanguard Personalized Indexing Management LLC bought a new position in Core Laboratories during the 2nd quarter valued at about $146,000. Praxis Investment Management Inc. purchased a new stake in shares of Core Laboratories during the 2nd quarter valued at about $155,000. AlphaQuest LLC boosted its holdings in shares of Core Laboratories by 504.4% during the 2nd quarter. AlphaQuest LLC now owns 16,071 shares of the oil and gas company’s stock valued at $185,000 after acquiring an additional 13,412 shares during the last quarter. Finally, Ingalls & Snyder LLC bought a new stake in shares of Core Laboratories in the second quarter worth approximately $115,000. 97.81% of the stock is owned by institutional investors.

Core Laboratories Company Profile

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.